LeMaitre Vascular, Inc. (LMAT)
77.65
-1.64
(-2.07%)
USD |
NASDAQ |
Nov 12, 16:00
77.66
+0.02
(+0.02%)
After-Hours: 20:00
LeMaitre Vascular Net Income (Quarterly) : 15.02M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 15.02M |
| June 30, 2026 | 17.05M |
| March 31, 2026 | 15.68M |
| December 31, 2025 | 15.58M |
| September 30, 2025 | 17.36M |
| June 30, 2025 | 13.78M |
| March 31, 2025 | 11.01M |
| December 31, 2024 | 11.18M |
| September 30, 2024 | 11.14M |
| June 30, 2024 | 11.83M |
| March 31, 2024 | 9.887M |
| December 31, 2023 | 8.465M |
| September 30, 2023 | 7.502M |
| June 30, 2023 | 8.098M |
| March 31, 2023 | 6.04M |
| December 31, 2022 | 5.627M |
| September 30, 2022 | 5.456M |
| June 30, 2022 | 3.515M |
| March 31, 2022 | 6.038M |
| December 31, 2021 | 6.175M |
| September 30, 2021 | 6.504M |
| June 30, 2021 | 8.299M |
| March 31, 2021 | 5.929M |
| December 31, 2020 | 7.033M |
| September 30, 2020 | 7.513M |
| Date | Value |
|---|---|
| June 30, 2020 | 3.50M |
| March 31, 2020 | 3.174M |
| December 31, 2019 | 4.613M |
| September 30, 2019 | 5.184M |
| June 30, 2019 | 4.624M |
| March 31, 2019 | 3.513M |
| December 31, 2018 | 6.025M |
| September 30, 2018 | 4.314M |
| June 30, 2018 | 8.751M |
| March 31, 2018 | 3.853M |
| December 31, 2017 | 4.284M |
| September 30, 2017 | 5.042M |
| June 30, 2017 | 4.632M |
| March 31, 2017 | 3.219M |
| December 31, 2016 | 2.597M |
| September 30, 2016 | 3.229M |
| June 30, 2016 | 2.598M |
| March 31, 2016 | 2.166M |
| December 31, 2015 | 2.53M |
| September 30, 2015 | 2.092M |
| June 30, 2015 | 1.767M |
| March 31, 2015 | 1.369M |
| December 31, 2014 | 1.916M |
| September 30, 2014 | 0.934M |
| June 30, 2014 | 1.272M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -5.471M |
| AtriCure, Inc. | 4.064M |
| Baxter International, Inc. | 298.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 67.97M |
| Total Expenses (Quarterly) | 52.95M |
| EPS Diluted (Quarterly) | 0.6512 |
| Enterprise Value | 1.576B |
| Gross Profit Margin (Quarterly) | 69.54% |
| Profit Margin (Quarterly) | 22.10% |
| Earnings Yield | 3.48% |
| Operating Earnings Yield | 4.11% |
| Normalized Earnings Yield | 3.484 |